S Tsagarakis
Overview
Explore the profile of S Tsagarakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Athanasiou N, Diamantopoulos A, Keskinidou C, Katsaounou P, Angelousi A, Jahaj E, et al.
J Endocrinol Invest
. 2023 Sep;
47(3):721-728.
PMID: 37702927
Purpose: We aimed to identify whether hypothalamic-pituitary-adrenal (HPA) axis dysfunction is related to deterioration in a percentage of patients who progress to severe COVID-19. Methods: In this cohort observational study,...
2.
Vassiliadi D, Mourelatos P, Kratimenos T, Tsagarakis S
Endocrine
. 2021 Jun;
73(3):530-539.
PMID: 34080096
In patients with ACTH-dependent Cushing's syndrome (CS), the differentiation between Cushing's disease (CD) and ectopic ACTH secretion (EAS) can often be challenging. The traditionally used biochemical tests have limited diagnostic...
3.
Vassiliadi D, Tsagarakis S
Eur J Endocrinol
. 2020 Apr;
182(6):C17-C19.
PMID: 32234974
Transsphenoidal surgery (TSS) is the treatment of choice in Cushing's disease. However, recurrence rates are substantial and currently there are no robust predictors of late prognosis. As accumulating evidence challenge...
4.
Stratigou T, Vallianou N, Vlassopoulou B, Tzanela M, Vassiliadi D, Ioannidis G, et al.
Diabetes Metab Syndr
. 2019 Jul;
13(2):1639-1641.
PMID: 31336534
Background: Diabetic ketoacidosis (DKA) has been related mainly to type 1 diabetes mellitus (T1DM). However, it is not solely related to T1DM. The purpose of this study was to assess...
5.
Vassiliadi D, Tsagarakis S
Endocrine
. 2018 May;
61(2):177-179.
PMID: 29774503
No abstract available.
6.
Vallianou N, Stratigou T, Paikopoulou A, Apostolou T, Vlassopoulou B, Tsagarakis S, et al.
Diabetes Metab Syndr
. 2018 Apr;
12(5):689-692.
PMID: 29685824
Background: The purpose of this study was to evaluate the outcome of DM2 patients with nephropathy when they are under surveillance of a joined clinic run by endocrinologists & nephrologists....
7.
Vassiliadi D, Tsagarakis S
Endocrine
. 2017 Feb;
56(3):453-455.
PMID: 28210938
No abstract available.
8.
Vassiliadi D, Balomenaki M, Asimakopoulou A, Botoula E, Tzanela M, Tsagarakis S
J Clin Endocrinol Metab
. 2016 Sep;
101(12):4878-4885.
PMID: 27662440
Context: Cushing's disease (CD) has a significant relapse rate after successful transsphenoidal surgery (TSS). Many CD patients respond aberrantly to the desmopressin test (DT). Disappearance of this response after surgery...
9.
Kanakis G, Chrisoulidou A, Bargiota A, Efstathiadou Z, Papanastasiou L, Theodoropoulou A, et al.
Clin Endocrinol (Oxf)
. 2016 Jun;
85(5):681-688.
PMID: 27292418
Objective: Growth hormone (GH) and insulin-like growth factor I (IGF-I) are the principal biomarkers used to assess disease activity in acromegaly, and any discrepancy between them renders interpretation of results...
10.
Perogamvros I, Vassiliadi D, Karapanou O, Botoula E, Tzanela M, Tsagarakis S
Eur J Endocrinol
. 2015 Sep;
173(6):719-25.
PMID: 26330465
Objective: The treatment of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas (AI) is debatable. We aimed to compare the biochemical and clinical outcome of unilateral adrenalectomy vs a conservative...